Optimization of a blood pool contrast agent injection protocol for MR angiography

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 5, 2005, Pages 611-619

  Robert, Philippe ^a,c   Violas, Xavier ^a   Santus, Robin ^a   Le Bihan, Denis ^b   Corot, Claire ^a  

^a Laboratoire Guerbet   (France)

^b DIF   (France)

^c Research Department   (France)

Author keywords

Animal model; Blood pool agents; Injection protocol; MR angiography; Pharmacokinetic

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOMELITOL; GADOTERIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; FIRST PASS EFFECT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RABBIT; SWINE;

ANIMALS; CONTRAST MEDIA; HETEROCYCLIC COMPOUNDS; INJECTIONS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS; RABBITS; SWINE;

EID: 17844388131     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20324     Document Type: Article

References (34)

1. Prince MR, Grist TM, Debatin J. 2003. Basic concepts. In: Springer, editor. 3D contrast MR angiography. New York: Springer-Verlag. 290 p.
2. Johansson L, Fischer S, Lorenz C. Benefit of T1 reduction for magnetic resonance coronary angiography: a numerical simulation and phantom study. J Magn Reson Imaging 1999;9:552-556.
3. Maki J, Prince MR, Londy FJ, Chenevert TL. The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality. J Magn Reson Imaging 1996;6:642-651.
4. Svensson J, Petersson JS, Stahlberg F, Larsson EM, Leander P, Olsson LE. Image artifacts due to a time-varying contrast medium concentration in 3D contrast-enhanced MRA. J Magn Reson Imaging 1999;10:919-928.
5. Taupitz M, Schnorr J, Wagner S, et al. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792. Magn Reson Med 2001;46: 932-938.
6. Dirksen MS, Lamb HJ, Kunz P, Robert P, Corot C, De Roos A. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs. Radiology 2003;227:802-808.
7. Reiser U. Study of bolus geometry after intravenous contrast medium injection: dynamic and quantitative measurements (chronogram) using an X-ray CT device. J Comput Assist Tomogr 1984;8: 251-262.
8. Hittmair K, Fleischmann D. Accuracy of predicting and controlling time-dependent aortic enhancement from a test bolus injection. J Comput Assist Tomogr 2001;25:287-294.
9. Bae KT, Tran HQ, Heiken JP. Multiphasic injection method for uniform prolonged vascular enhancement at CT angiography: pharmacokinetic analysis and experimental porcine model. Radiology 2000;216:872-880.
10. Fleischmann D, Rubin G, Bankier A, Hittmair K. Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 2000;214:363-371.
11. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology 1998;207:647-655.
12. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657-662.
13. Fleischmann D, Hittmair K. Mathematical analysis of arterial enhancement and optimization of bolus geometry for CT angiography using the discrete Fourier transform. J Comput Assist Tomogr 1999;23:474-484.
14. Corot C, Violas X, Robert P, Port M. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography. Invest Radiol 2000;35:213-218.
15. Hany T, McKinnon G, Leung D, Pfammatter T, Debatin J. Optimization of contrast timing for breath-hold three-dimensional MR angiography. J Magn Reson Imaging 1997;7:551-556.
16. Boos M, Scheffler K, Haselhorst R, Reese E, Frohlich J, Bongartz GM. Arterial first pass gadolinium-CM dynamics as a function of several intravenous NaCl flush and Gd volume. J Magn Reson Imaging 2001;13:568-576.
17. Maki J, Prince M, Chenevert T. Optimizing three-dimensional gadolinium-enhanced magnetic resonance angiography. Original investigation. Invest Radiol 1998;33:528-537.
18. Schoenberg SO, Londy FJ, Licato P, Williams DM, Wakefield T, Chenevert TL. Multiphase-multistep gadolinium-enhanced MR angiography of the abdominal aorta and runoff vessels. Invest Radiol 2001;36:283-291.
19. Zheng J, Bae KT, Woodard PK, Haacke EM, Li D. Efficacy of slow infusion of gadolinium contrast agent in three-dimensional MR coronary artery imaging. J Magn Reson Imaging 1999;10:800-805.
20. Czum JM, Ho VB, Hood MN, Foo TK, Choyke PL. Bolus-chase peripheral 3D MRA using a dual-rate contrast media injection. J Magn Reson Imaging 2000;12:769-775.
21. Wendland MF, Saeed M, Yu KK, et al. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med 1994;32:319-329.
22. Port M, Corot C, Raynal I, et al. Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Invest Radiol 2001;36:445-454.
23. Port M, Corot C, Rousseaux O, et al. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. MAGMA 2001;12:121-127.
24. Bourasset F, Dencausse A, Bourrinet P, Ducret M, Corot C. Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model. MAGMA 2001;12:82-87.
25. Gross DR. Normal cardiovascular parameters from intact, awake animals. Animal models in cardiovascular research. Dordrecht, The Netherlands: Kluwer Academic Publishers: 1994. p 343.
26. Lentner C, editor. Geigy scientific tables: heart and circulation. Vol. V. Basel, Switzerland: CIBA-GEIGY Corporation: 1990.
27. Wolfensohn S, Loeyd M. 1994. Handbook of laboratory animal management and welfare. London: Oxford University Press. 400 p.
28. Ruehm SG, Christina H, Violas X, Corot C, Debatin JF. MR angiography with a new rapid-clearance blood pool agent: initial experience in rabbits. Magn Reson Med 2002;48:844-851.
29. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.
30. Flamm SD, Muthupillai R. Coronary artery magnetic resonance angiography. J Magn Reson Imaging 2004;19:686-709.
31. Fain SB, Riederer SJ, Bernstein MA, Huston 3rd J. Theoretical limits of spatial resolution in elliptical-centric contrast-enhanced 3D-MRA. Magn Reson Med 1999;42:1106-1116.
32. Börnert P, Aldefeld B, Eggers H. Reversed spiral MR imaging. Magn Reson Med 2000;44:479-484.
33. Börnert P, Aldefeld B, Nehrke K, Eggers H. Reversed spiral imaging for coronary MR angiography. In: Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada, 2003.
34. Zheng J, Li D, Cavagna FM, et al. Contrast-enhanced coronary MR angiography: relationship between coronary artery delineation and blood T1. J Magn Reson Imaging 2001;14:348-354.